Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | CA1 | P00915 | 4/20 | 0.68 |
| ▸ | CA2 | P00918 | 4/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | TLR2 | O60603 | 1/20 | 0.57 |
| ▸ | ERN1 | O75460 | 1/20 | 0.57 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.57 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.57 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.55 |
| ▸ | EGFR | P00533 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3-Methoxycatechol SCHEMBL67332 | 1.00 | TP53 (1.00) | TP53ALDH1A1LMNAHPGDALOX15 | |
| 3-Methoxycatechol SCHEMBL11796213 | 0.97 | TP53 (0.95) | TP53ALDH1A1LMNAHPGDALOX15 | |
| Syringol SCHEMBL156388 | 0.89 | KDM4E (0.80) | TP53ALDH1A1LMNAHPGDALOX15 | |
| 3-Methoxycatechol SCHEMBL18396654 | 0.89 | TP53 (0.79) | TP53ALDH1A1LMNAHPGDALOX15 | |
| 3-Methoxycatechol SCHEMBL29636518 | 0.89 | TP53 (0.79) | TP53ALDH1A1LMNAHPGDALOX15 | |
| Guaiacol SCHEMBL14921410 | 0.88 | CA1 (0.82) | TP53ALDH1A1LMNAHPGDALOX15 | |
| 3-Methoxycatechol SCHEMBL3373824 | 0.87 | TP53 (0.76) | TP53ALDH1A1LMNAHPGDALOX15 | |
| Syringol SCHEMBL7610366 | 0.86 | KDM4E (0.76) | TP53ALDH1A1LMNAHPGDALOX15 | |
| Syringol SCHEMBL6049240 | 0.86 | KDM4E (0.76) | TP53ALDH1A1LMNAHPGDALOX15 | |
| Syringol SCHEMBL8986496 | 0.86 | KDM4E (0.76) | TP53ALDH1A1LMNAHPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4076841-A1 | BONDED ABRASIVE ARTICLE AND METHOD OF MAKING THE SAME | 3M Innovative Properties Company (US) | 2022-10-26 | — | — | EP | claimed |
| WO-2025104050-A1 | POLYMER AND COMPOSITION COMPRISING THE SAME | MERCK PATENT GMBH (DE) | 2025-05-22 | — | — | WO | disclosed |
| US-20240381867-A1 | BIO-OIL FRACTIONS COMPOSITION DERIVED FROM BIO-OIL | SUZANO S.A. (BR) | 2024-11-21 | — | — | US | disclosed |
| WO-2024189634-A1 | HIGHLY ATOM ECONOMICAL PROCESS FOR SYNTHESIS OF NOVEL CO-INITIATOR FOR PHOTO-INDUCED RADICAL POLYMERISATION | SHIV NADAR (INSTITUTION OF EMINENCE DEEMED TO BE UNIVERSITY) (IN) | 2024-09-19 | — | — | WO | disclosed |
| EP-4430131-A1 | COMPOSITION | Merck Patent GmbH (DE) | 2024-09-18 | — | — | EP | disclosed |
| CN-117836392-A | Biological oil fraction composition derived from biological oil | 苏扎诺公司 | 2024-04-05 | — | — | CN | disclosed |
| US-11939691-B2 | Tin or tin alloy electroplating bath, and electronic component having electrodeposit formed thereon using the plating bath | ISHIHARA CHEMICAL CO., LTD. (JP) | 2024-03-26 | — | — | US | disclosed |
| CN-112041296-B | Aminoacetamides containing benzooxy alicyclic structures and uses thereof | 上海璃道医药科技有限公司 | 2023-12-29 | — | — | CN | disclosed |
| WO-2023083834-A1 | COMPOSITION | MERCK PATENT GMBH (DE) | 2023-05-19 | — | — | WO | disclosed |
| EP-4126835-A1 | INHIBITORS OF ANTIGEN PRESENTATION BY HLA-DR | Janssen Pharmaceutica NV (BE) | 2023-02-08 | — | — | EP | disclosed |
| US-20230001543-A1 | BONDED ABRASIVE ARTICLE AND METHOD OF MAKING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2023-01-05 | — | — | US | disclosed |
| EP-4076841-A1 | BONDED ABRASIVE ARTICLE AND METHOD OF MAKING THE SAME | 3M Innovative Properties Company (US) | 2022-10-26 | — | — | EP | disclosed |
| EP-4021510-A2 | CONJUGATES AND CONJUGATES FOR USE IN PREVENTING OR TREATING OF BRAIN DAMAGE AND NEURODEGENERATIVE DISEASES | Medicortex Finland Oy (FI) | 2022-07-06 | — | — | EP | disclosed |
| CN-112844379-B | Method for preparing monophenol chemicals by catalyzing lignin depolymerization through ruthenium loaded on metal organic framework material derivative | 华南理工大学 | 2022-06-14 | — | — | CN | disclosed |
| US-20220125766-A1 | METHODS FOR TREATING CONGENITAL DISORDERS OF GLYCOSYLATION | MAGGIES PEARL LLC (US) | 2022-04-28 | — | — | US | disclosed |
| EP-3987086-A1 | METHOD FOR PREPARING HIGH-CONCENTRATION PENTA-TWINNED GOLD NANOPARTICLES | Université Claude Bernard Lyon 1 (FR) | 2022-04-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220125766-A1 | METHODS FOR TREATING CONGENITAL DISORDERS OF GLYCOSYLATION | MAN1B1, MAN2B1, GAA | TP53 2399/4885ALDH1A1 1692/4885LMNA 1508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.